Encompass Health Corp. Form 8-K Summary
Business Context and Reporting Period
Date of Report: June 25, 2025
Company: Encompass Health Corporation (EHC)
Filing Type: Form 8-K (Current Report)
Primary Event: Regulation FD Disclosure regarding the publication of an Investor Reference Book.
The filing serves to distribute an Investor Reference Book (Exhibit 99.1) containing an overview of the Company, its industry, business outlook, growth strategy, and operational initiatives. The information is furnished under Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics and Non-GAAP Measures
This filing does not contain specific GAAP financial results (revenue, net income, cash flow) for a specific reporting period. Instead, it defines the methodology for key non-GAAP measures used in the attached Investor Reference Book:
- Leverage Ratio: Defined as consolidated total debt to Adjusted EBITDA for the trailing four quarters. The credit agreement allows cash on hand to be deducted from total debt.
- Adjusted EBITDA: Used as a liquidity measure and a key component of credit agreement covenants. It adjusts consolidated net income by adding back interest, taxes, depreciation, amortization, and specific non-recurring items (capped at $10 million for cash expenditures).
- Adjusted Free Cash Flow: Defined as net cash provided by operating activities of continuing operations minus maintenance capital expenditures, distributions to noncontrolling interests, and certain non-indicative items. Common stock dividends are excluded.
Material Changes and Covenant Implications
The filing highlights the materiality of financial covenants within the Company's credit agreement:
- Covenant Compliance: The Company must maintain specific interest coverage and leverage ratios. Noncompliance could trigger immediate repayment of all borrowed amounts.
- Consequences of Violation: Potential covenant violations may restrict the Company from incurring additional debt, paying dividends, making certain payments, or acquiring/disposing of assets.
- Pro Forma Adjustments: The credit agreement permits the use of pro forma Adjusted EBITDA to account for dispositions, debt changes, and acquisitions not yet reflected in trailing financial statements.
Outlook, Risks, and Forward-Looking Statements
The filing includes extensive forward-looking statements regarding the Company's growth strategy and operational initiatives. Key risks identified include:
- Healthcare Environment: Infectious disease outbreaks affecting patient volumes and staffing; changes in Medicare regulations and reimbursement rates; increased audit activity.
- Operational Challenges: Staffing shortages for nurses and therapists; labor costs and union activity; integration of acquired systems and de novo developments.
- Macroeconomic Factors: Economic downturns, capital market instability, tariffs, trade wars, and federal budget impasses.
- Legal and Regulatory: Adverse outcomes in lawsuits, regulatory proceedings, and environmental or employment regulations.
Investor Verification Checklist
- Review the attached Investor Reference Book (Exhibit 99.1) for specific numerical values regarding leverage ratios, Adjusted EBITDA, and Adjusted Free Cash Flow, as this 8-K only defines the metrics.
- Verify the Company's current compliance status with the interest coverage and leverage ratio covenants in its credit agreement.
- Assess the impact of Medicare payment reviews and appeals on the backlog of denied claims and future revenue recognition.
- Monitor labor market conditions and their effect on staffing costs and patient care delivery.
- Examine the reconciliation of non-GAAP measures to GAAP net income and operating cash flow in the Investor Reference Book to understand the magnitude of adjustments.